Biopolym. Cell. 2002; 18(1):26-36.
Огляди
Антигенні властивості фібриногензв'язуючих білків та їхня роль у патогенезі стафілококових інфекцій. Фібриногензв'язуючі білки клітинної стінки
1Іванова В. Д., 1Позур В. К.
  1. Київський національний університет імені Тараса Шевченка
    вул. Володимирська 64, Київ, Україна, 01033

Abstract

Поверхневі фібриногензв'язуючі білки забезпечують адгезію бактерій до тканин організму хазяїна і є важливими факторами ініціювання та розвитку стафілококових інфекцій. Крім пластівцевоутворюючого фактора, фібриногензв'язуючою активністю володіють фібронектинзв'язуючий білок, фібриногензв'язуючий білок та аналог білків МНС II класу. В даному огляді розглянуто структуру, особливості взаємодії з фібриногеном та біологічні властивості поверхневих фібри­ногензв'язуючих білків Staphylococcus aureus, які мають значення для розшифрування патогенезу стафілококової інфекції.

References

[1] Kuusela P, Vartio T, Vuento M, Myhre EB. Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phase. Infect Immun. 1985;50(1):77-81.
[2] Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, Peters G, Waldvogel FA. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis. 1988;158(4):693-701.
[3] Hook M, McGavin MJ, Switalski LM, Raja R, Raucci G, Lindgren PE, Lindberg M, Signas C. Interactions of bacteria with extracellular matrix proteins. Cell Differ Dev. 1990;32(3):433-8.
[4] O'Connell DP, Nanavaty T, McDevitt D, Gurusiddappa S, H??k M, Foster TJ. The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem. 1998;273(12):6821-9.
[5] Vaudaux PE, Fran?ois P, Proctor RA, McDevitt D, Foster TJ, Albrecht RM, Lew DP, Wabers H, Cooper SL. Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun. 1995;63(2):585-90.
[6] Cheung AL, Fischetti VA. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis. 1990;161(6):1177-86.
[7] Cheung AL, Krishnan M, Jaffe EA, Fischetti VA. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest. 1991;87(6):2236-45.
[8] Dickinson RB, Nagel JA, McDevitt D, Foster TJ, Proctor RA, Cooper SL. Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun. 1995;63(8):3143-50.
[9] Wolz C, McDevitt D, Foster TJ, Cheung AL. Influence of agr on fibrinogen binding in Staphylococcus aureus Newman. Infect Immun. 1996;64(8):3142-7.
[10] Bod?n MK, Flock JI. Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog. 1992;12(4):289-98.
[11] McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994;11(2):237-48.
[12] N? Eidhin D, Perkins S, Francois P, Vaudaux P, H??k M, Foster TJ. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol. 1998;30(2):245-57.
[13] Cheung AI, Projan SJ, Edelstein RE, Fischetti VA. Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect Immun. 1995;63(5):1914-20.
[14] Wann ER, Gurusiddappa S, Hook M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem. 2000;275(18):13863-71.
[15] J?nsson K, McDevitt D, McGavin MH, Patti JM, H??k M. Staphylococcus aureus expresses a major histocompatibility complex class II analog. J Biol Chem. 1995;270(37):21457-60.
[16] Bod?n MK, Flock JI. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun. 1989;57(8):2358-63.
[17] Palma M, Haggar A, Flock JI. Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol. 1999;181(9):2840-5.
[18] Jeljaszewicz J. Staphylocoagulase and clumping factor. Staphylococci and staphylococcal infections. Eds C. S. F. Easmon, C. Adlan. London: Acad, press, 1983. Vol. 2: 525-43.
[19] Foster TJ, H??k M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998;6(12):484-8.
[20] Schneewind O, Fowler A, Faull KF. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science. 1995;268(5207):103-6.
[21] Josefsson E, McCrea KW, N? Eidhin D, O'Connell D, Cox J, H??k M, Foster TJ. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology. 1998;144 ( Pt 12):3387-95.
[22] Duthie ES. Evidence for two forms of staphylococcal coagulase. J Gen Microbiol. 1954;10(3):427-36.
[23] McDevitt D, Vaudaux P, Foster TJ. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992;60(4):1514-23.
[24] Usui Y. Biochemical properties of fibrinogen binding protein (clumping factor) of the staphylococcal cell surface. Zentralbl Bakteriol Mikrobiol Hyg A. 1986;262(3):287-97.
[25] Vaudaux P, Pittet D, Haeberli A, Huggler E, Nydegger UE, Lew DP, Waldvogel FA. Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis. 1989;160(5):865-75.
[26] Mempel M, Schmidt T, Weidinger S, Schnopp C, Foster T, Ring J, Abeck D. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol. 1998;111(3):452-6.
[27] Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Fran?ois P, Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63(12):4738-43.
[28] Sawai T, Tomono K, Yanagihara K, Yamamoto Y, Kaku M, Hirakata Y, Koga H, Tashiro T, Kohno S. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun. 1997;65(2):466-71.
[29] Hartford O, Francois P, Vaudaux P, Foster TJ. The dipeptide repeat region of the fibrinogen-binding protein (clumping factor) is required for functional expression of the fibrinogen-binding domain on the Staphylococcus aureus cell surface. Mol Microbiol. 1997;25(6):1065-76.
[30] McDevitt D, Francois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995;16(5):895-907.
[31] Hartford OM, Wann ER, H??k M, Foster TJ. Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) that are important for ligand binding. J Biol Chem. 2001;276(4):2466-73.
[32] Brown EM, Vassilev PM, Hebert SC. Calcium ions as extracellular messengers. Cell. 1995;83(5):679-82.
[33] Uhl?n M, Guss B, Nilsson B, Gatenbeck S, Philipson L, Lindberg M. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem. 1984;259(3):1695-702.
[34] Hartford O, McDevitt D, Foster TJ. Matrix-binding proteins of Staphylococcus aureus: functional analysis of mutant and hybrid molecules. Microbiology. 1999;145 ( Pt 9):2497-505.
[35] van Belkum A, Scherer S, van Alphen L, Verbrugh H. Short-sequence DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev. 1998;62(2):275-93.
[36] McDevitt D, Foster TJ. Variation in the size of the repeat region of the fibrinogen receptor (clumping factor) of Staphylococcus aureus strains. Microbiology. 1995;141 ( Pt 4):937-43.
[37] Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF. Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Ann N Y Acad Sci. 1983;408:521-35.
[38] McDevitt D, Nanavaty T, House-Pompeo K, Bell E, Turner N, McIntire L, Foster T, H??k M. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem. 1997;247(1):416-24.
[39] Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun. 1995;63(9):3634-41.
[40] Altieri DC, Plescia J, Plow EF. The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion. J Biol Chem. 1993;268(3):1847-53.
[41] Lee JO, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell. 1995;80(4):631-8.
[42] Entenza JM, Foster TJ, Ni Eidhin D, Vaudaux P, Francioli P, Moreillon P. Contribution of clumping factor B to pathogenesis of experimental endocarditis due to Staphylococcus aureus. Infect Immun. 2000;68(9):5443-6.
[43] Hasche KD, Br?ckler J, Schaeg W, Blobel H. Influence of "clumping factor" from Staphylococcus aureus on phagocytosis (author's transl). Zentralbl Bakteriol Orig A. 1975;232(4):446-53.
[44] Hermann M, Jaconi ME, Dahlgren C, Waldvogel FA, Stendahl O, Lew DP. Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest. 1990;86(3):942-51.
[45] Espersen F, Clemmensen I. Immunization of mice with the fibronectin-binding protein and clumping factor from Staphylococcus aureus: antibody response and resistance against intraperitoneal infection. Acta Pathol Microbiol Immunol Scand C. 1985;93(2):53-8.
[46] Colque-Navarro P, Palma M, S?derquist B, Flock JI, M?llby R. Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol. 2000;7(1):14-20.
[47] Greene C, McDevitt D, Francois P, Vaudaux PE, Lew DP, Foster TJ. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol Microbiol. 1995;17(6):1143-52.
[48] Proctor RA, Hamill RJ, Mosher DF, Textor JA, Olbrantz PJ. Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother. 1983;12 Suppl C:85-95.
[49] Switalski LM, Ryd?n C, Rubin K, Ljungh A, H??k M, Wadstr?m T. Binding of fibronectin to Staphylococcus strains. Infect Immun. 1983;42(2):628-33.
[50] Flock JI, Hienz SA, Heimdahl A, Schennings T. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect Immun. 1996;64(5):1876-8.
[51] Sinha B, Francois P, Que YA, Hussain M, Heilmann C, Moreillon P, Lew D, Krause KH, Peters G, Herrmann M. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun. 2000;68(12):6871-8.
[52] Patti JM, Allen BL, McGavin MJ, H??k M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585-617.
[53] House-Pompeo K, Xu Y, Joh D, Speziale P, H??k M. Conformational changes in the fibronectin binding MSCRAMMs are induced by ligand binding. J Biol Chem. 1996;271(3):1379-84.
[54] Casolini F, Visai L, Joh D, Conaldi PG, Toniolo A, H??k M, Speziale P. Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections. Infect Immun. 1998;66(11):5433-42.
[55] Speziale P, Joh D, Visai L, Bozzini S, House-Pompeo K, Lindberg M, H??k M. A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae. J Biol Chem. 1996;271(3):1371-8.
[56] Luk JM, Flock JI, Wadstr?m T. Detection in rabbit sera of blocking antibodies against staphylococcal fibronectin-binding protein by enzyme-linked immunosorbent assay. FEMS Microbiol Immunol. 1989;1(8-9):505-10.
[57] Sun Q, Smith GM, Zahradka C, McGavin MJ. Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding. Infect Immun. 1997;65(2):537-43.
[58] Mamo W, Jonsson P, M?ller HP. Opsonization of Staphylococcus aureus with a fibronectin-binding protein antiserum induces protection in mice. Microb Pathog. 1995;19(1):49-55.
[59] Rozalska B, Wadstr?m T. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Scand J Immunol. 1993;37(5):575-80.
[60] Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog. 1993;15(3):227-36.
[61] McGavin MH, Krajewska-Pietrasik D, Ryd?n C, H??k M. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun. 1993;61(6):2479-85.